APA (7th ed.) Citation

SI, P., EEW, C., D, L., G, F., ES, K., H, M., . . . N, S. (2019). SUPREME-HN: A retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Journal of translational medicine, 17(1), 429. https://doi.org/10.1186/s12967-019-02182-1

Chicago Style (17th ed.) Citation

SI, Pai, et al. "SUPREME-HN: A Retrospective Biomarker Study Assessing the Prognostic Value of PD-L1 Expression in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck." Journal of Translational Medicine 17, no. 1 (2019): 429. https://doi.org/10.1186/s12967-019-02182-1.

MLA (9th ed.) Citation

SI, Pai, et al. "SUPREME-HN: A Retrospective Biomarker Study Assessing the Prognostic Value of PD-L1 Expression in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck." Journal of Translational Medicine, vol. 17, no. 1, 2019, p. 429, https://doi.org/10.1186/s12967-019-02182-1.